The biosimilar is manufactured by JHL’s Taiwanese subsidiary. It is the first company from the Greater China to secure European approval for clinical trial of a monoclonal antibody
Merck received a complete response letter from the agency. The company said it will review the letter and determine its next steps. The applications were based on the
The drug also improved erythroid response, an important measure of the formation of new red blood cells. The company said data from the phase 3 Arcade study was
Cormorant Asset Management, Hillhouse Capital Group and venBio Global Strategic Fund led the Series D preferred-stock financing. Existing investors Morningside Venture Investments, AJU IB Investment, and Epidarex Capital
The UK High Court decided that the Alimta vitamin regimen patent would not currently be infringed by Actavis marketing pemetrexed trometamol in the UK, France, Italy and Spain
The companies did not disclose the financial terms of the transaction. Pfizer will retain commercialization and manufacturing rights to infliximab in all countries outside the EEA. Sandoz aims
Novartis unit Sandoz is seeking approval for the similar indication as the reference product. The company’s marketing authorization application is supported by three pivotal clinical trials, which demonstrate
A planned interim analysis of Janus 1 phase 3 study showed that ruxolitinib plus capecitabine did not demonstrate a sufficient level of efficacy to warrant continuation. The primary
The Renal Pre-Competitive Consortium (RPC2) will develop and utilize large-scale data exploration to find new treatment targets for CKD. It will combine the R&D expertise of the pharmaceutical
The selected solutions include Oracle Siebel Clinical Trial Management System and Oracle Health Sciences Clinical Development Analytics. Oracle Siebel Clinical Trial Management System allows global clinical organizations to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.